• 1
    Finnie TJ, Hall IM, Leach S. Behaviour and control of influenza in institutions and small societies. J R Soc Med 2012; 105:6673.
  • 2
    Lee VJ, Tan CH, Yap J et al. Effectiveness of pandemic H1N1-2009 vaccination in reducing laboratory confirmed influenza infections among military recruits in tropical Singapore. PLoS One 2011; 6:e26572.
  • 3
    Strickler JK, Hawksworth AW, Myers C, Irvine M, Ryan MAK, Russell KL. Influenza vaccine effectiveness among US military basic trainees, 2005–06 season. Emerg Infect Dis 2007; 13:617619.
  • 4
    Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:3644.
  • 5
    Pebody RG, Andrews N, Fleming DM et al. Age-specific influenza effectiveness of seasonal 2010/2011 and pandemic Influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect 2012; 13:111.
  • 6
    Treanor JJ, Talbot HK, Ohmit SE et al. Effectiveness of seasonal influenza vaccines in the United States during a season with all three vaccine strains. Clin Infect Dis 2012; 55:951959.
  • 7
    Jimenez-Jorge S, de Mateo S, Pozo F et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill 2012; 17. Available at:
  • 8
    Bonmarin I, Belchior E, Le Strat Y, Lévy-Bruhl D. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill 2012; 17. Available at:
  • 9
    Harper SA, Bradley JS, Englund JA et al. Seasonal influenza in adults and children – diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the infectious disease society of America. Clin Infect Dis 2009; 48:10031032.
  • 10
    Ong AK, Chen MI, Lin L et al. Improving the clinical diagnosis of influenza—a comparative analysis of new influenza A (H1N1) cases. PLoS One 2009; 4: e8453.
  • 11
    Gerdil C. The annual production cycle for influenza vaccine. Vaccine 2003; 21:17761779.
  • 12
    U.S. Morbidity and Mortality Weekly Report. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Atlanta: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services; 2010.
  • 13
    Orenstein EW, de Serres G, Haber MJ et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623631.
  • 14
    Fielding JE, Grant KA, Tran T, Kelly HA. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. Euro Surveill 2012; 17:pii 20115. Available at:
  • 15
    R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. 2012 ISBN 3-900051-07-0.
  • 16
    Kissling E, Valenciano M. I-MOVE case-control studies team. Early estimates of seasonal influenza effectiveness in Europe among target groups of vaccination: results from the I-MOVE multicentre case-control study 2011/2012. Euro Surveill 17:20146. Available at:
  • 17
    Skowronski DM, Masaro C, Kwindt TL et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25:28422851.
  • 18
    Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007; 25:68526862.
  • 19
    Wang M, Yuan J, Li T et al. Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China. PLoS One 2011; 6:e16809.
  • 20
    Beyer WEP, de Bruijn IA, Palache AM, Westendorp RGJ, Osterhaus ADME. Protection against influenza after annually repeated vaccination a meta-analysis of serologic and field studies. Arch Intern Med 1999; 159:182188.
  • 21
    Nokleby H, Nicoll A. Risk groups and other target groups – preliminary ECDC guidance for developing influenza vaccination recommendations for the season 2010–11. Euro Surveill 2010;15:pii 19525. Available at:
  • 22
    Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults; in Nicholson KG, Webster RG, Hay AJ (eds): Textbook of Influenza. Malden, MA: Blackwell Science, 1998; 360.